Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-13

Clinical Trial Update: Omega-3 Supplements to Reduce Antisocial Behaviour in Young Offenders [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on omega-3 supplements to reduce antisocial behavior in young offenders, reported across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 supplements (omega-3 fatty acids)

Snippet

Sponsor: Singapore Prison Service | Conditions: Antisocial Behavior | Phase 2, Phase 3 | Status: COMPLETED